STAAR Surgical Company (STAA) Receives Approval to Market STAAR Visian™
STAAR Surgical Company, a leading developer, marketer and manufacturer announced the approval from the State Food and Drug Administration of the People’s Republic of China for the go ahead in the marketing of STAAR Visian™ Toric Implantable Collamar Lens to eye care professionals for the treatment of astigmatism and nearsightedness. Barry G. Caldwell, President and CEO of STAAR Surgical noted, “This approval has significant strategic importance for STAAR and positions us for continued growth in China. The approval of both the Visian Toric ICL and the Visian Hyperopic ICL represents a solid endorsement of the STAAR technology. The Visian Myopic…